## **Core Concept**
Choriocarcinoma is a type of gestational trophoblastic neoplasia (GTN) that is highly malignant and has a high potential for metastasis. The prognosis of choriocarcinoma depends on several factors, including the patient's age, antecedent pregnancy, interval months from index pregnancy, hCG level, largest tumor diameter, and site of metastasis.

## **Why the Correct Answer is Right**
The correct answer, , indicates that a high level of beta-hCG is a bad prognostic factor for choriocarcinoma. Beta-hCG is a tumor marker for choriocarcinoma, and high levels often correlate with a larger tumor burden and more aggressive disease. The FIGO (International Federation of Gynecology and Obstetrics) scoring system, which is used to predict the prognosis of patients with GTN, including choriocarcinoma, takes into account the beta-hCG level among other factors.

## **Why Each Wrong Option is Incorrect**
- **Option A:** is not a widely recognized prognostic factor for choriocarcinoma in the same context as beta-hCG levels, tumor size, or site of metastasis.
- **Option B:** does not directly relate to commonly accepted prognostic factors for choriocarcinoma.
- **Option C:** is not specified, making it impossible to assess its relevance.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for choriocarcinoma is that patients with a high FIGO score (which includes factors like high beta-hCG levels, large tumor size, and distant metastases) have a poorer prognosis and may require more aggressive chemotherapy and closer follow-up.

## **Correct Answer:** . High beta-hCG level.